KD

KKR's Dawn Biopharma

Venture Capital

Part of KKR

Dawn Biopharma is an investment platform controlled by KKR Healthcare Strategic Growth Fund II, focused on building a diverse portfolio of biopharma companies. Founded in 2022.

United States

Growth
Biotech
Healthcare
Headquarters
United States
Founded
2022

Overview

KKR's Dawn Biopharma is a Venture Capital firm based in United States.